These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 31736389)
1. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery. Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389 [TBL] [Abstract][Full Text] [Related]
2. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle. Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation. Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219 [TBL] [Abstract][Full Text] [Related]
4. Novel Mitochondrial Targeting Multifunctional Surface Charge-Reversal Polymeric Nanoparticles for Cancer Treatment. Fang L; Fan H; Guo C; Cui L; Zhang P; Mu H; Xu H; Zhao F; Chen D J Biomed Nanotechnol; 2019 Nov; 15(11):2151-2163. PubMed ID: 31847930 [TBL] [Abstract][Full Text] [Related]
5. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy. Liu M; Wang B; Guo C; Hou X; Cheng Z; Chen D Drug Deliv; 2019 Dec; 26(1):1002-1016. PubMed ID: 31571501 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer. Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799 [TBL] [Abstract][Full Text] [Related]
8. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer. Wang B; Zhang W; Zhou X; Liu M; Hou X; Cheng Z; Chen D Drug Deliv; 2019 Dec; 26(1):1265-1279. PubMed ID: 31777307 [TBL] [Abstract][Full Text] [Related]
9. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632 [TBL] [Abstract][Full Text] [Related]
10. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy. Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794 [TBL] [Abstract][Full Text] [Related]
11. Novel Dual Mitochondrial and CD44 Receptor Targeting Nanoparticles for Redox Stimuli-Triggered Release. Wang K; Qi M; Guo C; Yu Y; Wang B; Fang L; Liu M; Wang Z; Fan X; Chen D Nanoscale Res Lett; 2018 Feb; 13(1):32. PubMed ID: 29396830 [TBL] [Abstract][Full Text] [Related]
12. Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis. Hou X; Lin H; Zhou X; Cheng Z; Li Y; Liu X; Zhao F; Zhu Y; Zhang P; Chen D Carbohydr Polym; 2020 Mar; 232():115787. PubMed ID: 31952595 [TBL] [Abstract][Full Text] [Related]
13. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy. Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695 [TBL] [Abstract][Full Text] [Related]
14. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition. Wei X; Senanayake TH; Bohling A; Vinogradov SV Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100 [TBL] [Abstract][Full Text] [Related]
15. Curcumin-loaded redox response of self-assembled micelles for enhanced antitumor and anti-inflammation efficacy. Zhao S; Ma L; Cao C; Yu Q; Chen L; Liu J Int J Nanomedicine; 2017; 12():2489-2504. PubMed ID: 28408820 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways. Song J; Lin C; Yang X; Xie Y; Hu P; Li H; Zhu W; Hu H J Control Release; 2019 Jan; 294():27-42. PubMed ID: 30445003 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466 [TBL] [Abstract][Full Text] [Related]
18. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy. Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433 [TBL] [Abstract][Full Text] [Related]
19. Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors. Zhang Y; Zhou J; Yang C; Wang W; Chu L; Huang F; Liu Q; Deng L; Kong D; Liu J; Liu J Int J Nanomedicine; 2016; 11():1119-30. PubMed ID: 27051287 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG containing curcumin: In vitro evaluation and pharmacokinetics in rats. Xu Y; Asghar S; Yang L; Chen Z; Li H; Shi W; Li Y; Shi Q; Ping Q; Xiao Y Int J Biol Macromol; 2017 Sep; 102():1083-1091. PubMed ID: 28472690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]